identify & characterize new, potent & selective ligands with e3scan ligand-binding assay technology
Published 1 year ago • 228 plays • Length 2:44Download video MP4
Download video MP3
Similar videos
-
45:51
paradigm shift in drug discovery: discover small molecule degraders using e3scan technology platform
-
37:35
next-generation drug discovery: leveraging e3 ligases for targeted protein degradation
-
24:20
leveraging the e3scantm technology platform for next-generation targeted protein degradation
-
5:00
types of assays used in early drug discovery
-
12:58
eurofins discoverx internalization assays
-
2:03
find your next novel kinase inhibitor with the kinomescan technology
-
17:46
recent trends in kinase drug discovery
-
4:22
discover versiti diagnostic labs, clinical trials and biomaterials | versiti
-
1:01:06
[recorded webinar] protac — developing new therapies through targeted protein degradation
-
7:19
verdict diagnostic & information system | snap-on tools
-
59:46
edrx webinar the value of gpcr cell based assays in drug discovery
-
1:05:12
eurofins discovery services
-
0:43
set up reference values for lab tests
-
1:18
functional element discovery .... the interpretation of how variants effect function - joseph ecker
-
25:02
eurofins discovery case study: understanding tpd complexity using biomap® human phenotypic platform
-
31:06
eurofins discoverx gpcr assays
-
1:28
exagen inc.- discover the difference
-
6:17
understanding binding kinetics in drug discovery workshop(1/3)
-
28:04
decoding cancer and inflammation: identifying selective inhibitors of sh2 domains
-
5:49
segmenting 101 part ii: what's a data extension?
-
1:40
how to: view pedigree tree on animal performance plus web